Ferit GÜRSU, Reşat ÖZERCAN, Suat TÜRKOĞLU, Mehmet Hamdi MUZ, Gamze KIRKIL

Oleik asit ile oluşturulan akut akciğer hasarı modelinde likopenin etkileri

Introduction: This study, we aimed to investigate the protective effect of lycopene in lung injury rat model.Materials and Methods: Twenty eight Wistar rats were enrolled into the study. Control group (n= 7) were applied PBS + et-hanol (9/1). A single dose of 100 mg/kg oleic acid (OA) intravenously was administrated to OA group (n= 7). One mL of cornoil was given daily to corn oil + OA group (n= 7) by gavage for five weeks. Lycopene was given by gavage to lycopene + OAgroup (n= 7) for five weeks. At the end of the 5thweeks, OA were given. Four hour after OA administration, lung tissue, blo-od samples were taken. Malondialdehyde, superoxide dismutase, glutathione-peroxidase, catalase levels were determined.Results: Malondialdehyde levels of serum, lung tissues were increased in OA, corn oil + OA groups than control, where asdecreased to controls levels in lycopene + OA group (p< 0.05). Superoxide dismutase, glutathione-peroxidase activities ofserum, tissue increased moderetaly or they were closed with control values. There was significant increase in lycopene +OA group values. Histopathological examination of control group was normal. OA, cornoil + OA groups had perivascular,alveolar edema, hemorrage, prominent neutrophil infiltration, destruction in alveolar structure. Lycopene + OA group hadless neutrophilic infiltration, perivascular, alveolar edema.Conclusion: Lycopene rich diet may have an important role preventing damages in lungs.

PDF

___

1.Repine JE. Scientific perspectives on adult respiratory distress syndrome. Lancet 1992; 339: 466-9.
2.Ware LB, Matthay MA. The acute respiratory distress syndro- me. N Engl J Med 2000; 342: 1334-9.
3.Metnitz PG, Bartens C, Fischer M, Fridrich P, Steltzer H, Druml W. Antioxidant status in patients with acute respiratory dist- ress syndrome. Intensive Care Med 1999; 25: 180-5.
4.Pittet JF, Mackersie RC, Martin TR, Matthay MA. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med 1997; 155: 1187-205.
5.Schuster DP. ARDS: clinical lessons from oleic acid model of acute lung injury. Am J Respir Crit Care Med 1994; 149: 245-60.
6.Koksel O, Cinel I, Tamer L, Cinel L, Ozdulger A, Kanik A, et al. N-acetylcysteine inhibits peroxynitrite-mediated damage in oleic acid-induced lung injury. Pulm Pharmacol Ther 2004; 17: 263-70.
7.Stahl W, Sies H. Bioactivity and protective effects of natural carotenoids. Biochim Biophys Acta 2005; 1740: 101-7.
8.Bramley PM. Regulation of carotenoid formation during toma- to fruit ripening and development. J Exp Bot 2002; 53: 2107-13.
9.Michaud DS, Feskanich D, Rimm EB, Colditz GA, Speizer FE, Willett WC, et al. Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts. Am J Clin Nutr 2000; 72: 990-7.
10.Velmurugan B, Bhuvaneswari V, Nagini S. Antiperoxidative ef- fects of lycopene during N-methyl-N'-nitro-N-nitrosoguanidine- induced gastric carcinogenesis. Fitoterapia 2002; 73: 604-11.
11.Satoh K. Serum lipid peroxide in cerebrovascular disorders de- terminde by a new colorimetric method. Clin Chim Acta 1978; 90: 37-43.
12.Yagi K. Assay for blood plasma or serum. Methods in Enzymol 1984; 105: 328-31.
13.Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in ani- mal tissues by thiobarbituric acid reaction. Analytical Bioche- mistry 1979; 95; 351-8.
14.Sun Y, Oberley LW, Ying L. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
15.Durak I, Yurtarslanı Z, Canpolat O, Akyol O. A methodologi- cal approach to superoxide dismutase activity assay based on inhibition of nitroblue tetrazolium reduction. Clin Chim Acta 1993; 214: 103-4.
16.Paglia DE, Valentine WN. Studies on the quantitative and qu- alitative characterization of erythrocyte glutathione peroxida- se. J Lab Clin Med 1967; 70: 158-69.
17.Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-6.
18.Ozdulger A, Cinel I, Koksel O, Cinel L, Avlan D, Unlu A, et al. The protective effect of N-acetylcysteine on apoptotic lung in- jury in cecal ligation and puncture-induced sepsis model. Shock 2003; 19: 366-72.
19.MacNee W, Rahman I. Oxidants and antioxidants as therape- utic targets in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 558-65.
20.Ozaras R, Tahan V, Turkmen S, Talay F, Besirli K, Aydin S, et al. Changes in malondialdehyde levels in bronchoalveolar flu- id and serum by the treatment of asthma with inhaled stero- id and beta2-agonist. Respirology 2000; 5: 289-92.
21.Oliveira-Junior IS, Brunialti MK, Koh IH, Junqueira VB, Salo- mão R. Effect of pentoxifylline on lung inflammation and gas exchange in a sepsis-induced acute lung injury model. Braz J Med Biol Res 2006; 39: 1455-63.
22.Meyancı G, Arıcıoglu F, Oz H, Aydemir A. The effects of int- ratrcheal dexamethasone on lipid peroxidation in acute lung injury. Cerrahpasa J Med 2001; 32: 20-4.
23.Demirbilek S, Sizanli EE, Karaman A, et al. Effects of Methyle- ne Blue on Lung Injury in Septic Rats. Journal of Inonu Uni- versity Medical Faculty 2004; 11: 207-11.
24.Karahan I, Yılmaz S, Atessahin A. Effects of Lycopene on cisp- latin and gentamicin induced oxidative stres in blood and li- ver in rats. Firat University Medical Journal of Health Sciences 2006; 20: 39-43.
25.Velmurugan B, Nagini S. Combination chemoprevention of ex- perimental gastric carcinogenesis by s-allylcysteine and lyco- pene: modulatory effects on glutathione redox cycle antioxi- dants. J Med Food 2005; 8: 494-501.
26.Koksel O, Kaplan MB, Ozdulger A, Tamer L, Degirmenci U, Ci- nel L, et al. Oleic acid-induced lung injury in rats and effects of caffeic acid phenethyl ester. Exp Lung Res 2005; 31: 483-96.
27.Gadek JE, Pacht ER. The interdependence of lung antioxi- dants and antiprotease defense in ARDS. Chest 1996; 110 (Suppl 6): S273-S7.
28.Liu H, Zhang D, Zhao B, Zhao J. Superoxide anion, the main species of ROS in the development of ARDS induced by oleic acid. Free Radic Res 2004; 38: 1281-7.
29.Leff JA, Parsons PE, Day CE, Moore EE, Moore FA, Oppegard MA, et al. Increased serum catalase activity in septic patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1992; 146: 985-9.
30.Pacht ER, Timerman AP, Lykens MG, Merola AJ. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 1991; 100: 1397-403.
31.Brigham KL. Role of free radicals in lung injury. Chest 1986; 9: 59-63.
32.Breinholt V, Lauridsen ST, Daneshvar B, Jakobsen J. Dose res- ponse effects of lycopene on selected drug-metabolizing and antioxidant enzymes in the rat. Cancer Letters 2000; 154: 201- 10.
33.Neuman I, Nahum H, Ben-Amotz A. Reduction of exercise-in- duced asthma oxidative stress by lycopene a natural antioxi- dant. Allergy 2000; 55: 1184-9.
34.Arab L, Steck-Scott S, Fleishauer AT. Lycopene and the lung. Exp Biol Med (Maywood) 2002; 227: 894-9.
35.Heber D, Lu QY. Overview of mechanisms of action of lycope- ne. Exp Biol Med (Maywood) 2002; 227: 920-3.
36.Gultekin FA, Kerem M, Tatlicioglu E, Aricioglu A, Unsal C, Bu- kan N. Leptin treatment ameliorates acute lung injury in rats with cerulein-induced acute pancreatitis. World J Gastroente- rol 2007; 13: 2932-8.